TuHURA Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $263.0K | $2.4M |
| FY2021 | — | $10.6M | $10.5M |
| FY2022 | — | $11.8M | $11.8M |
| FY2023 | — | $731.0K | $1.5M |
| FY2024 | — | $3.8M | $4.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $263.0K | $2.4M |
| FY2021 | — | $10.6M | $10.5M |
| FY2022 | — | $11.8M | $11.8M |
| FY2023 | — | $731.0K | $1.5M |
| FY2024 | — | $3.8M | $4.9M |